Income, insurance, and technology: Why does health spending outpace economic growth?

Health Affairs

Volumn 28, Issue 5, 2009, Pages 1276-1284

  Smith, Sheila ^a   Newhouse, Joseph P ^b   Freeland, Mark S ^a  

^a CENTERS FOR MEDICARE AND MEDICAID SERVICES   (United States)

^b HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ECONOMIC ASPECT; ECONOMIC DEVELOPMENT; FINANCIAL MANAGEMENT; GOVERNMENT; HEALTH CARE COST; HEALTH CARE MANAGEMENT; HEALTH INSURANCE; INCOME; MEDICAL TECHNOLOGY;

ECONOMIC DEVELOPMENT; HEALTH EXPENDITURES; HUMANS; INCOME; INSURANCE COVERAGE; INSURANCE POOLS; TECHNOLOGY, MEDICAL;

EID: 70349197847     PISSN: 02782715     EISSN: 15445208     Source Type: Journal    
DOI: 10.1377/hlthaff.28.5.1276     Document Type: Article

References (29)

1. Hartman M, Martin A, McDonnell P, Catlin A, et al. National health spending in 2007: slower drug spending contributes to lowest rate of overall growth since 1998. Health Aff (Millwood). 2009;28(1):246-261
2. Ginsburg P. High and rising health care costs: demystifying U.S. health care spending. Princeton (NJ): Robert Wood Johnson Foundation; 2008. Research Synthesis Report no. 18.
3. Fuchs V. Economics, values, and healthcare reform. Am Econ Rev. 1996;86(1):1-24.
4. Newhouse JP. Medical care costs: how much welfare loss? J Econ Perspect. 1992;6(3):3-21.
5. Newhouse JP. An iconoclastic view of cost containment. Health Aff (Millwood). 1993;12 Suppl:152-171
6. For a concise summary of the findings of this literature, see Cohen AB, Hanft R. Technology and American health care. Ann Arbor (MI): University of Michigan Press; 2004. p. 19-20.
7. See the technical appendix at http://content.healthaffairs.org/cgi/ content/full/28/5/1276/DC1.
8. Manning W, et al. Health insurance and the demand for medical care: results from a randomized experiment. Amer Econ Rev. 1987;77(3):251-277
9. Newhouse J, Health Insurance Experiment Group. Free for all? Lessons from the RAND Health Insurance Experiment. Cambridge (MA): Harvard University Press; 1993.
10. Getzen TE. Health care is an individual necessity and a national luxury: applying multilevel decision models to the analysis of health care expenditures. J Health Econ. 2000;19(2):259-270
11. Finkelstein A. The aggregate effects of health insurance: evidence from the introduction of Medicare. QJ Econ. 2007;122(1):1-37.
12. Newhouse J. Medical care expenditure: a cross-national survey. J Human Res. 1977;12(1):115-125 (Pubitemid 8192646)
13. Gerdtham U, Jönsson B. International comparisons of health expenditure. In: Culyer AJ, Newhouse JP, editors. Handbook of health economics. Amsterdam (Netherlands): North-Holland; 2000. p. 11-53.
14. Finkelstein A. Static and dynamic effects of health policy: evidence from the vaccine industry. Q J Econ. 2004;119(2):527-564 (Pubitemid 38706647)
15. Acemoglu D. Market size in innovation: theory and evidence from the pharmaceutical industry. Q J Econ. 2004;119(3):1049-1090 (Pubitemid 39057314)
16. Acemoglu D, Finkelstein A. Income and health spending: evidence from oil price shocks. Cambridge (MA): National Bureau of Economic Research; 2009. Working Paper no. 14744.
17. Weisbrod B. The health care quadrilemma: an essay on technological change, insurance, quality of care, and cost containment. J Econ Lit. 1991;29(3):523-552
18. Berndt ER, Cutler D, Frank RG. Medical care prices and output. In: Culyer AJ, Newhouse JP, editors. Handbook of health economics. Amsterdam (Netherlands): Elsevier; 2000. p. 120-180
19. Ho MS, Samuels JD. Appendix B: measuring industry output and intermediate inputs. In: An intertemporal general equilibrium model of U.S. health expenditures. Cambridge (MA): Dale Jorgenson Associates; 2006.
20. Baumgardner J. The interaction between forms of insurance contract and types of technical change in medical care. RAND J Econ. 1991;22:36-53.
21. Garber A. Insurance and incentives for medical innovation. Cambridge (MA): National Bureau of Economic Research; 2006. Working Paper no. 12080. Incentives for innovation in drugs and devices need to consider the world market, but the United States historically was a substantial proportion of that market.
22. Frank R, Zeckhauser R. Custom-made versus ready-to-wear treatments: behavioral propensities in physicians' choices. J Health Econ. 2007;26(6):1101-1127 (Pubitemid 350166636)
23. Sogaard J. Decomposition of the aggregate income elasticity in health care using panel data [Internet]. Copenhagen (Denmark): Danish Institute for Health Services Research; 2000 [cited 2009 Jun 24]. Available from: http://www.nek.lu.se/ryde/luche99/Papers/econpapers/sogaard.pdf
24. This range reflects variation in sample across countries or time. Estimates for later time periods tend to be on the lower end of this range.
25. Moise P. The technology-health expenditures link. In: A disease-based comparison of health systems. Paris (France): Organization for Economic Cooperation and Development; 2003. p. 27-50.
26. Baumol WJ. Macroeconomics of unbalanced growth. Amer Econ Rev. 1967;57(3):415-426
27. Phelps CE. The demand for reimbursement insurance. In: Rosett R, editor. The role of health insurance in the health services sector. Cambridge (MA): National Bureau of Economic Research; 1976.
28. Centers for Medicare and Medicaid Services. Projections of national health expenditures: methodology and model specification [Internet]. Baltimore (MD): CMS; 2009 [cited 2009 Jun 24]. Available from: http://www.cms.hhs.gov/ NationalHealthExpendData/downloads/projections-methodology.pdf
29. This assumes that the effect of insurance on spending does not increase.